인플루엔자 진단 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2025-2032년)

Influenza Diagnostics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032

US $ 4,995 ￦ 7,148,000

Unprintable PDF & Excel (Single User License)

PDF, Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트의 복사, 인쇄가 불가능합니다.

US $ 7,295 ￦ 10,440,000

PDF & Excel (Multi User License)

PDF, Excel 보고서를 동일 기업 내 5명까지 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

US $ 8,495 ￦ 12,158,000

PDF & Excel (Corporate User License)

PDF, Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 텍스트의 Copy&Paste와 인쇄가 가능합니다.

한글목차

주요 인사이트

• 인플루엔자 진단 시장 규모 : 18억 330만 달러(2025년)
• 예상 시장 규모 : 27억 1,150만 달러(2032년)
• 세계 시장 성장률 : 6.00%(2025-2032년 CAGR)

인플루엔자 진단 시장 - 보고서 범위

인플루엔자 진단 시장은 A형, B형, C형 인플루엔자를 포함한 인플루엔자 바이러스의 검출 및 식별에 사용되는 진단 도구의 개발 및 보급에 초점을 맞추고 있습니다. 이 시장은 계절성 인플루엔자 및 유행성 인플루엔자 유행의 증가, 신속하고 정확한 진단 검사에 대한 수요 증가, 분자 검사 및 혈청학 검사의 기술적 진보에 의해 주도되고 있습니다. 질병 발생을 억제하기 위한 조기 및 정확한 검출에 대한 수요 증가와 의료 인프라에 대한 투자 증가는 시장 확대를 더욱 촉진하고 있습니다.

시장 성장 촉진요인

세계 인플루엔자 진단 시장은 전 세계 인플루엔자 감염 부담 증가, 질병 조기 발견에 대한 인식 증가, 진단 기술 발전 등 여러 요인으로 인해 큰 성장세를 보이고 있습니다. 정부와 의료 기관은 인플루엔자 감시와 대비에 중점을 두고 있으며, 이는 인플루엔자 진단 검사의 채택을 더욱 촉진하고 있습니다. 또한, 현장 검사에 대한 수요와 분자진단 방법의 확대가 시장 성장을 촉진하고 있습니다.

시장 억제요인

분자진단은 큰 성장이 예상되는 반면, 높은 분자진단 비용과 일부 지역에서는 첨단 의료시설에 대한 접근성이 제한적이라는 문제점에 직면해 있습니다. 신속진단 검사(RIDT)의 정확성은 위음성 결과가 적시 치료에 영향을 미칠 수 있기 때문에 여전히 우려의 대상이 되고 있습니다. 규제 장벽과 진단 키트의 까다로운 승인 절차도 시장 확대를 지연시킬 수 있습니다.

시장 기회

인플루엔자 진단 시장에는 혁신적인 고감도 검사 솔루션 개발, 진단 플랫폼에 AI 통합 등 큰 성장 기회가 있습니다. 신흥 시장 진출과 현장 검사 솔루션에 대한 투자는 시장 침투를 촉진할 수 있습니다. 또한, 진단 제조업체와 의료 서비스 제공자와의 전략적 제휴를 통해 제품의 접근성과 가용성을 향상시켜 시장 수요를 더욱 증가시킬 수 있습니다.

이 보고서는 세계 인플루엔자 진단 시장을 조사하여 성장 촉진요인, 동향, 기회, 과제 등 시장 역학에 대한 상세한 분석을 제공합니다.

목차

제1장 주요 요약

제2장 시장 개요

• 시장 범위/분류
• 시장 정의/범위/제한
• 포함과 제외

제3장 주요 시장 동향

• 시장에 영향을 미치는 주요 동향
• 제품의 혁신/개발 동향

제4장 중요한 성공요인

• 제품 채용/이용 분석
• 제품 USP/특징
• 전략과 프로모션 전략
• 주요 규제
• 질병 역학
• PESTLE 분석
• Porters 분석

제5장 시장 배경

• 거시경제 요인
• 예측요인 - 관련성과 영향
• 역학

제6장 COVID-19 위기 분석

• COVID-19와 영향 분석
  • 검사별
  • 인플루엔자 유형별
  • 최종사용자별
• 시장 시나리오(2022년)

제7장 세계의 인플루엔자 진단 시장 전망(2019-2032년)

• 시장 금액 실적 분석(2019-2024년)
• 현재와 향후 시장 금액 예측(2025-2032년)
  • 전년비 성장 동향 분석
  • 절대적 수익 기회 분석

제8장 세계의 인플루엔자 진단 시장 전망 : 검사별(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 검사별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 검사별(2025-2032년)
  • 분자진단 검사
  • 기존 진단 검사
• 시장 매력 분석 : 검사별

제9장 인플루엔자 진단 시장 전망 : 인플루엔자 유형별(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 인플루엔자 유형별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 인플루엔자 유형별(2025-2032년)
  • A형 인플루엔자
  • B형 인플루엔자
  • C형 인플루엔자
• 시장 매력 분석 : 인플루엔자 유형별

제10장 인플루엔자 진단 시장 전망 : 최종사용자별(2019-2032년)

• 소개/주요 조사 결과
• 시장 규모 실적 분석 : 최종사용자별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 최종사용자별(2025-2032년)
  • 병원
  • 진단 검사실
  • 연구·학술기관
  • 임상시험수탁기관(CRO)
• 시장 매력 분석 : 최종사용자별

제11장 인플루엔자 진단 시장 전망 : 지역별(2019-2032년)

• 소개
• 시장 규모 실적 분석 : 지역별(2019-2024년)
• 현재와 향후 시장 규모 분석과 예측 : 지역별(2025-2032년)
  • 북미
  • 라틴아메리카
  • 유럽
  • 남아시아
  • 동아시아
  • 오세아니아
  • 중동 및 아프리카
• 시장 매력 분석 : 지역별

제12장 북미의 인플루엔자 진단 시장 전망(2019-2032년)

제13장 라틴아메리카의 인플루엔자 진단 시장 전망(2019-2032년)

제14장 유럽의 인플루엔자 진단 시장 전망(2019-2032년)

제15장 남아시아의 인플루엔자 진단 시장 전망(2019-2032년)

제16장 동아시아의 인플루엔자 진단 시장 전망(2019-2032년)

제17장 오세아니아의 인플루엔자 진단 시장 전망(2019-2032년)

제18장 중동 및 아프리카의 인플루엔자 진단 시장 전망(2019-2032년)

제19장 시장 구조 분석

• 시장 분석 : 기업 Tier별
• 주요 기업의 시장 점유율 분석
• 시장 집중
• 시장 입지 분석

제20장 경쟁 분석

• 경쟁 대시보드
• 경쟁 상세
  • Abbott Laboratories
  • Endress+Hauser(Analytik Jena AG)
  • Becton, Dickinson and Company
  • Biocartis
  • bioMerieux Inc
  • Danaher Corporation(Cepheid)
  • F. Hoffmann-La Roche Ltd
  • GenMark Diagnostics, Inc.
  • Luminex Corporation
  • Meridian Bioscience, Inc
  • Quidel Corporation
  • Thermo Fisher Scientific Inc.
  • Hologic

제21장 사용되는 가정과 두문자어

제22장 조사 방법

ksm

영문 목차

영문목차

Persistence Market Research has recently released a comprehensive report on the global Influenza Diagnostics Market, providing an in-depth analysis of key market dynamics, including driving factors, emerging trends, opportunities, and challenges. This report offers a detailed understanding of the market landscape, enabling stakeholders to make well-informed decisions.

Key Insights:

• Influenza Diagnostics Market Size (2025E): USD 1,803.30 Mn
• Projected Market Value (2032F): USD 2,711.50 Mn
• Global Market Growth Rate (CAGR 2025 to 2032): 6.00%

Influenza Diagnostics Market - Report Scope:

The Influenza Diagnostics Market focuses on the development and adoption of diagnostic tools used to detect and identify influenza viruses, including influenza A, B, and C. The market is driven by the rising prevalence of seasonal and pandemic influenza, increasing demand for rapid and accurate diagnostic tests, and technological advancements in molecular and serological testing. The growing need for early and precise detection to curb disease outbreaks, along with increased investment in healthcare infrastructure, is further fueling market expansion.

Market Growth Drivers:

The global Influenza Diagnostics Market is experiencing significant growth due to multiple factors, including the increasing burden of influenza infections worldwide, rising awareness of early disease detection, and advancements in diagnostic technologies. Governments and healthcare organizations are emphasizing influenza surveillance and preparedness, further driving the adoption of influenza diagnostic tests. Additionally, the demand for point-of-care testing and the expansion of molecular diagnostic methods are propelling market growth.

Market Restraints:

Despite strong growth prospects, the market faces challenges such as high costs associated with molecular diagnostics and limited access to advanced healthcare facilities in certain regions. The accuracy of rapid diagnostic tests (RIDTs) remains a concern, as false-negative results can impact timely treatment. Regulatory hurdles and stringent approval processes for diagnostic kits may also slow market expansion.

Market Opportunities:

The Influenza Diagnostics Market presents substantial growth opportunities, including the development of innovative, high-sensitivity testing solutions and the integration of artificial intelligence (AI) in diagnostic platforms. Expansion into emerging markets and investments in point-of-care testing solutions can drive market penetration. Additionally, strategic collaborations between diagnostic manufacturers and healthcare providers will enhance product accessibility and affordability, further boosting market demand.

Key Questions Answered in the Report:

• What are the major factors driving global growth in the Influenza Diagnostics Market?
• How are molecular diagnostic advancements shaping the future of influenza testing?
• Which diagnostic tests are witnessing the highest adoption rates?
• Who are the key players in the Influenza Diagnostics Market, and what strategies are they implementing?
• What are the emerging trends and market projections for influenza diagnostics?

Competitive Intelligence and Business Strategy:

Leading companies in the Influenza Diagnostics Market, such as Abbott Laboratories, Becton, Dickinson and Company, and Thermo Fisher Scientific Inc., are focusing on technological innovations, product launches, and strategic partnerships to strengthen their market presence. Companies are investing in molecular diagnostics, point-of-care testing, and AI-driven diagnostic solutions to enhance influenza detection accuracy and speed. Collaborations with research institutions and healthcare organizations help expand their market footprint and improve accessibility to advanced diagnostic solutions.

Key Companies Profiled:

• Abbott Laboratories
• Endress+Hauser (Analytik Jena AG)
• Becton, Dickinson and Company
• Biocartis
• bioMerieux Inc.
• Danaher Corporation (Cepheid)
• F. Hoffmann-La Roche Ltd
• GenMark Diagnostics, Inc.
• Luminex Corporation
• Meridian Bioscience, Inc.
• Quidel Corporation
• Thermo Fisher Scientific Inc.
• Hologic

Influenza Diagnostics Industry Research by Category:

By Test Type:

• Molecular Diagnostic Test
• Traditional Diagnostic Test
• H1N1 Influenza A Virus Identification Kits
• Immunoassay Kits
• Immunofluorescence Antibody Assay

By Type of Flu:

• Type A Flu
• Type B Flu
• Type C Flu

By End User:

• Hospitals
• Diagnostic Laboratories
• Research & Academic Institutes
• Contract Research Organizations (CROs)

By Region:

• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East & Africa

Table of Contents

1. Executive Summary

• 1.1. Global Market Outlook
• 1.2. Demand Side Trends
• 1.3. Supply Side Trends
• 1.4. Analysis and Recommendations

2. Market Overview

• 2.1. Market Coverage / Taxonomy
• 2.2. Market Definition / Scope / Limitations
• 2.3. Inclusions and Exclusions

3. Key Market Trends

• 3.1. Key Trends Impacting the Market
• 3.2. Product Innovation / Development Trends

4. Key Success Factors

• 4.1. Product Adoption / Usage Analysis
• 4.2. Product USPs / Features
• 4.3. Strategic and Promotional Strategies
• 4.4. Key Regulations
• 4.5. Disease Epidemiology
• 4.6. PESTLE Analysis
• 4.7. Porter's Analysis

5. Market Background

• 5.1. Macro-Economic Factors
  • 5.1.1. Global GDP Growth Outlook
  • 5.1.2. Global Healthcare Market Outlook
  • 5.1.3. Global Infectious Disease Diagnostics Market Overview
• 5.2. Forecast Factors - Relevance & Impact
  • 5.2.1. Top Influenza Diagnostics Companies & their Historical Growth
  • 5.2.2. Application Innovation in Influenza Diagnostics
  • 5.2.3. Product Adoption Rate
  • 5.2.4. Regulatory Impositions
  • 5.2.5. Growing R&D Investments
  • 5.2.6. Novel Diagnostic Product Development Activities
  • 5.2.7. Awareness Campaigns for Influenza Diagnostics
• 5.3. Dynamics
  • 5.3.1. Drivers
  • 5.3.2. Restraints
  • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis Analysis

• 6.1. COVID-19 and Impact Analysis
  • 6.1.1. By Test
  • 6.1.2. By Type of Flu
  • 6.1.3. By End User
• 6.2. 2022 Market Scenario

7. Global Influenza Diagnostics Market Outlook, 2019-2032

• 7.1. Historical Market Value (US$ Mn) Analysis, 2019-2024
• 7.2. Current and Future Market Value (US$ Mn) Projections, 2025-2032
  • 7.2.1. Y-o-Y Growth Trend Analysis
  • 7.2.2. Absolute $ Opportunity Analysis

8. Global Influenza Diagnostics Market Outlook, 2019-2032, By Test

• 8.1. Introduction / Key Findings
• 8.2. Historical Market Size (US$ Mn) Analysis By Test, 2019-2024
• 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Test, 2025-2032
  • 8.3.1. Molecular Diagnostics Tests
    • 8.3.1.1. RT-PCR
    • 8.3.1.2. LAMP
    • 8.3.1.3. NASABA
  • 8.3.2. Traditional Diagnostics Tests
    • 8.3.2.1. Rapid Influenza Detection Kits
    • 8.3.2.2. Serological Assays
    • 8.3.2.3. Direct Fluorescent Antibody
    • 8.3.2.4. Viral Culture
    • 8.3.2.5. H1N1 Influenza A Virus Identification Kits
    • 8.3.2.6. Immunoassay Kits
    • 8.3.2.7. Immunofluorescence Antibody Assay
• 8.4. Market Attractiveness Analysis By Test

9. Global Influenza Diagnostics Market Outlook, 2019-2032, By Type of Flu

• 9.1. Introduction / Key Findings
• 9.2. Historical Market Size (US$ Mn) Analysis By Type of Flu, 2019-2024
• 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type of Flu, 2025-2032
  • 9.3.1. Type A Flu
  • 9.3.2. Type B Flu
  • 9.3.3. Type C Flu
• 9.4. Market Attractiveness Analysis By Type of Flu

10. Global Influenza Diagnostics Market Outlook, 2019-2032, by End User

• 10.1. Introduction / Key Findings
• 10.2. Historical Market Size (US$ Mn) Analysis By End User, 2019-2024
• 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By End User, 2025-2032
  • 10.3.1. Hospitals
  • 10.3.2. Diagnostic Laboratories
  • 10.3.3. Research & Academic Institutes
  • 10.3.4. Contract Research Organizations (CRO)
• 10.4. Market Attractiveness Analysis By End User

11. Global Influenza Diagnostics Market Outlook, 2019-2032, by Region

• 11.1. Introduction
• 11.2. Historical Market Size (US$ Mn) Analysis By Region, 2019-2024
• 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Region, 2025-2032
  • 11.3.1. North America
  • 11.3.2. Latin America
  • 11.3.3. Europe
  • 11.3.4. South Asia
  • 11.3.5. East Asia
  • 11.3.6. Oceania
  • 11.3.7. Middle East and Africa (MEA)
• 11.4. Market Attractiveness Analysis By Region

12. North America Influenza Diagnostics Market Outlook, 2019 - 2032

• 12.1. Introduction
• 12.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 12.3.1. By Country
    • 12.3.1.1. U.S.
    • 12.3.1.2. Canada
  • 12.3.2. By Test
  • 12.3.3. By Type of Flu
  • 12.3.4. By End User
• 12.4. Market Attractiveness Analysis
  • 12.4.1. By Country
  • 12.4.2. By Test
  • 12.4.3. By Type of Flu
  • 12.4.4. By End User
• 12.5. Country Level Analysis & Forecast
  • 12.5.1. U.S. Influenza Diagnostics Market Analysis
    • 12.5.1.1. Introduction
    • 12.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 12.5.1.2.1. By Test
      • 12.5.1.2.2. By Type of Flu
      • 12.5.1.2.3. By End User
  • 12.5.2. Canada Influenza Diagnostics Market Analysis
    • 12.5.2.1. Introduction
    • 12.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 12.5.2.2.1. By Test
      • 12.5.2.2.2. By Type of Flu
      • 12.5.2.2.3. By End User
• 12.6. Market Trends
• 12.7. Key Market Participants - Intensity Mapping
• 12.8. Drivers and Restraints - Impact Analysis
• 12.9. Country Level Analysis & Forecast

13. Latin America Influenza Diagnostics Market Outlook, 2019 - 2032

• 13.1. Introduction
• 13.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 13.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 13.3.1. By Country
    • 13.3.1.1. Brazil
    • 13.3.1.2. Mexico
    • 13.3.1.3. Argentina
    • 13.3.1.4. Rest of Latin America
  • 13.3.2. By Test
  • 13.3.3. By Type of Flu
  • 13.3.4. By End User
• 13.4. Market Attractiveness Analysis
  • 13.4.1. By Country
  • 13.4.2. By Test
  • 13.4.3. By Type of Flu
  • 13.4.4. By End User
• 13.5. Country Level Analysis & Forecast
  • 13.5.1. Brazil Influenza Diagnostics Market Analysis
    • 13.5.1.1. Introduction
    • 13.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.1.2.1. By Test
      • 13.5.1.2.2. By Type of Flu
      • 13.5.1.2.3. By End User
  • 13.5.2. Mexico Influenza Diagnostics Market Analysis
    • 13.5.2.1. Introduction
    • 13.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.2.2.1. By Test
      • 13.5.2.2.2. By Type of Flu
      • 13.5.2.2.3. By End User
  • 13.5.3. Argentina Influenza Diagnostics Market Analysis
    • 13.5.3.1. Introduction
    • 13.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 13.5.3.2.1. By Test
      • 13.5.3.2.2. By Type of Flu
      • 13.5.3.2.3. By End User
• 13.6. Market Trends
• 13.7. Key Market Participants - Intensity Mapping
• 13.8. Drivers and Restraints - Impact Analysis
• 13.9. Country Level Analysis & Forecast

14. Europe Influenza Diagnostics Market Outlook, 2019-2032

• 14.1. Introduction
• 14.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 14.3.1. By Country
    • 14.3.1.1. Germany
    • 14.3.1.2. France
    • 14.3.1.3. Italy
    • 14.3.1.4. U.K.
    • 14.3.1.5. Spain
    • 14.3.1.6. Russia
    • 14.3.1.7. BENELUX
    • 14.3.1.8. Rest of Europe
  • 14.3.2. By Test
  • 14.3.3. By Type of Flu
  • 14.3.4. By End User
• 14.4. Market Attractiveness Analysis
  • 14.4.1. By Country
  • 14.4.2. By Test
  • 14.4.3. By Type of Flu
  • 14.4.4. By End User
• 14.5. Country Level Analysis & Forecast
  • 14.5.1. Germany Influenza Diagnostics Market Analysis
    • 14.5.1.1. Introduction
    • 14.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.1.2.1. By Test
      • 14.5.1.2.2. By Type of Flu
      • 14.5.1.2.3. By End User
  • 14.5.2. France Influenza Diagnostics Market Analysis
    • 14.5.2.1. Introduction
    • 14.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.2.2.1. By Test
      • 14.5.2.2.2. By Type of Flu
      • 14.5.2.2.3. By End User
  • 14.5.3. Italy Influenza Diagnostics Market Analysis
    • 14.5.3.1. Introduction
    • 14.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.3.2.1. By Test
      • 14.5.3.2.2. By Type of Flu
      • 14.5.3.2.3. By End User
  • 14.5.4. U.K. Influenza Diagnostics Market Analysis
    • 14.5.4.1. Introduction
    • 14.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.4.2.1. By Test
      • 14.5.4.2.2. By Type of Flu
      • 14.5.4.2.3. By End User
  • 14.5.5. Spain Influenza Diagnostics Market Analysis
    • 14.5.5.1. Introduction
    • 14.5.5.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.5.2.1. By Test
      • 14.5.5.2.2. By Type of Flu
      • 14.5.5.2.3. By End User
  • 14.5.6. Russia Influenza Diagnostics Market Analysis
    • 14.5.6.1. Introduction
    • 14.5.6.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.6.2.1. By Test
      • 14.5.6.2.2. By Type of Flu
      • 14.5.6.2.3. By End User
  • 14.5.7. BENELUX Influenza Diagnostics Market Analysis
    • 14.5.7.1. Introduction
    • 14.5.7.2. Market Analysis and Forecast by Market Taxonomy
      • 14.5.7.2.1. By Test
      • 14.5.7.2.2. By Type of Flu
      • 14.5.7.2.3. By End User
• 14.6. Market Trends
• 14.7. Key Market Participants - Intensity Mapping
• 14.8. Drivers and Restraints - Impact Analysis
• 14.9. Country Level Analysis & Forecast

15. South Asia Influenza Diagnostics Market Outlook, 2019 - 2032

• 15.1. Introduction
• 15.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 15.3.1. By Country
    • 15.3.1.1. India
    • 15.3.1.2. Thailand
    • 15.3.1.3. Indonesia
    • 15.3.1.4. Malaysia
    • 15.3.1.5. Rest of South Asia
  • 15.3.2. By Test
  • 15.3.3. By Type of Flu
  • 15.3.4. By End User
• 15.4. Market Attractiveness Analysis
  • 15.4.1. By Country
  • 15.4.2. By Test
  • 15.4.3. By Type of Flu
  • 15.4.4. By End User
• 15.5. Country Level Analysis & Forecast
  • 15.5.1. India Influenza Diagnostics Market Analysis
    • 15.5.1.1. Introduction
    • 15.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.1.2.1. By Test
      • 15.5.1.2.2. By Type of Flu
      • 15.5.1.2.3. By End User
  • 15.5.2. Thailand Influenza Diagnostics Market Analysis
    • 15.5.2.1. Introduction
    • 15.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.2.2.1. By Test
      • 15.5.2.2.2. By Type of Flu
      • 15.5.2.2.3. By End User
  • 15.5.3. Indonesia Influenza Diagnostics Market Analysis
    • 15.5.3.1. Introduction
    • 15.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.3.2.1. By Test
      • 15.5.3.2.2. By Type of Flu
      • 15.5.3.2.3. By End User
  • 15.5.4. Malaysia Influenza Diagnostics Market Analysis
    • 15.5.4.1. Introduction
    • 15.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 15.5.4.2.1. By Test
      • 15.5.4.2.2. By Type of Flu
      • 15.5.4.2.3. By End User
• 15.6. Market Trends
• 15.7. Key Market Participants - Intensity Mapping
• 15.8. Drivers and Restraints - Impact Analysis
• 15.9. Country Level Analysis & Forecast

16. East Asia Influenza Diagnostics Market Outlook, 2019 - 2032

• 16.1. Introduction
• 16.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 16.3.1. By Country
    • 16.3.1.1. China
    • 16.3.1.2. Japan
    • 16.3.1.3. South Korea
  • 16.3.2. By Test
  • 16.3.3. By Type of Flu
  • 16.3.4. By End User
• 16.4. Market Attractiveness Analysis
  • 16.4.1. By Country
  • 16.4.2. By Test
  • 16.4.3. By Type of Flu
  • 16.4.4. By End User
• 16.5. Country Level Analysis & Forecast
  • 16.5.1. China Influenza Diagnostics Market Analysis
    • 16.5.1.1. Introduction
    • 16.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.1.2.1. By Test
      • 16.5.1.2.2. By Type of Flu
      • 16.5.1.2.3. By End User
  • 16.5.2. Japan Influenza Diagnostics Market Analysis
    • 16.5.2.1. Introduction
    • 16.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.2.2.1. By Test
      • 16.5.2.2.2. By Type of Flu
      • 16.5.2.2.3. By End User
  • 16.5.3. South Korea Influenza Diagnostics Market Analysis
    • 16.5.3.1. Introduction
    • 16.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 16.5.3.2.1. By Test
      • 16.5.3.2.2. By Type of Flu
      • 16.5.3.2.3. By End User
• 16.6. Market Trends
• 16.7. Key Market Participants - Intensity Mapping
• 16.8. Drivers and Restraints - Impact Analysis
• 16.9. Country Level Analysis & Forecast

17. Oceania Influenza Diagnostics Market Outlook, 2019-2032

• 17.1. Introduction
• 17.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 17.3.1. By Country
    • 17.3.1.1. Australia
    • 17.3.1.2. New Zealand
  • 17.3.2. By Test
  • 17.3.3. By Type of Flu
  • 17.3.4. By End User
• 17.4. Market Attractiveness Analysis
  • 17.4.1. By Country
  • 17.4.2. By Test
  • 17.4.3. By Type of Flu
  • 17.4.4. By End User
• 17.5. Country Level Analysis & Forecast
  • 17.5.1. Australia Influenza Diagnostics Market Analysis
    • 17.5.1.1. Introduction
    • 17.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.1.2.1. By Test
      • 17.5.1.2.2. By Type of Flu
      • 17.5.1.2.3. By End User
  • 17.5.2. New Zealand Influenza Diagnostics Market Analysis
    • 17.5.2.1. Introduction
    • 17.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 17.5.2.2.1. By Test
      • 17.5.2.2.2. By Type of Flu
      • 17.5.2.2.3. By End User
• 17.6. Market Trends
• 17.7. Key Market Participants - Intensity Mapping
• 17.8. Drivers and Restraints - Impact Analysis
• 17.9. Country Level Analysis & Forecast

18. Middle East and Africa Influenza Diagnostics Market Outlook, 2019 - 2032

• 18.1. Introduction
• 18.2. Historical Market Size (US$ Mn) Analysis By Market Taxonomy, 2019-2024
• 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2025-2032
  • 18.3.1. By Country
    • 18.3.1.1. GCC Countries
    • 18.3.1.2. Turkey
    • 18.3.1.3. South Africa
    • 18.3.1.4. North Africa
    • 18.3.1.5. Rest of Middle East and Africa
  • 18.3.2. By Test
  • 18.3.3. By Type of Flu
  • 18.3.4. By End User
• 18.4. Market Attractiveness Analysis
  • 18.4.1. By Country
  • 18.4.2. By Test
  • 18.4.3. By Type of Flu
  • 18.4.4. By End User
• 18.5. Country Level Analysis & Forecast
  • 18.5.1. GCC Countries Influenza Diagnostics Market Analysis
    • 18.5.1.1. Introduction
    • 18.5.1.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.1.2.1. By Test
      • 18.5.1.2.2. By Type of Flu
      • 18.5.1.2.3. By End User
  • 18.5.2. Turkey Influenza Diagnostics Market Analysis
    • 18.5.2.1. Introduction
    • 18.5.2.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.2.2.1. By Test
      • 18.5.2.2.2. By Type of Flu
      • 18.5.2.2.3. By End User
  • 18.5.3. South Africa Influenza Diagnostics Market Analysis
    • 18.5.3.1. Introduction
    • 18.5.3.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.3.2.1. By Test
      • 18.5.3.2.2. By Type of Flu
      • 18.5.3.2.3. By End User
  • 18.5.4. North Africa Influenza Diagnostics Market Analysis
    • 18.5.4.1. Introduction
    • 18.5.4.2. Market Analysis and Forecast by Market Taxonomy
      • 18.5.4.2.1. By Test
      • 18.5.4.2.2. By Type of Flu
      • 18.5.4.2.3. By End User
• 18.6. Drivers and Restraints - Impact Analysis
• 18.7. Market Trends
• 18.8. Key Market Participants - Intensity Mapping
• 18.9. Country Level Analysis & Forecast

19. Market Structure Analysis

• 19.1. Market Analysis by Tier of Companies
• 19.2. Market Share Analysis of Top Players
• 19.3. Market Concentration
• 19.4. Market Presence Analysis

20. Competition Analysis

• 20.1. Competition Dashboard
• 20.2. Competition Deep Dive
  • 20.2.1. Abbott Laboratories
    • 20.2.1.1. Overview
    • 20.2.1.2. Product Portfolio
    • 20.2.1.3. Key Financials
    • 20.2.1.4. Sales Footprint
    • 20.2.1.5. Strategy Overview
      • 20.2.1.5.1. Marketing Strategy
      • 20.2.1.5.2. Product Strategy
      • 20.2.1.5.3. Channel Strategy
  • 20.2.2. Endress+Hauser (Analytik Jena AG)
    • 20.2.2.1. Overview
    • 20.2.2.2. Product Portfolio
    • 20.2.2.3. Key Financials
    • 20.2.2.4. Sales Footprint
    • 20.2.2.5. Strategy Overview
      • 20.2.2.5.1. Marketing Strategy
      • 20.2.2.5.2. Product Strategy
      • 20.2.2.5.3. Channel Strategy
  • 20.2.3. Becton, Dickinson and Company
    • 20.2.3.1. Overview
    • 20.2.3.2. Product Portfolio
    • 20.2.3.3. Key Financials
    • 20.2.3.4. Sales Footprint
    • 20.2.3.5. Strategy Overview
      • 20.2.3.5.1. Marketing Strategy
      • 20.2.3.5.2. Product Strategy
      • 20.2.3.5.3. Channel Strategy
  • 20.2.4. Biocartis
    • 20.2.4.1. Overview
    • 20.2.4.2. Product Portfolio
    • 20.2.4.3. Key Financials
    • 20.2.4.4. Sales Footprint
    • 20.2.4.5. Strategy Overview
      • 20.2.4.5.1. Marketing Strategy
      • 20.2.4.5.2. Product Strategy
      • 20.2.4.5.3. Channel Strategy
  • 20.2.5. bioMerieux Inc
    • 20.2.5.1. Overview
    • 20.2.5.2. Product Portfolio
    • 20.2.5.3. Key Financials
    • 20.2.5.4. Sales Footprint
    • 20.2.5.5. Strategy Overview
      • 20.2.5.5.1. Marketing Strategy
      • 20.2.5.5.2. Product Strategy
      • 20.2.5.5.3. Channel Strategy
  • 20.2.6. Danaher Corporation (Cepheid)
    • 20.2.6.1. Overview
    • 20.2.6.2. Product Portfolio
    • 20.2.6.3. Key Financials
    • 20.2.6.4. Sales Footprint
    • 20.2.6.5. Strategy Overview
      • 20.2.6.5.1. Marketing Strategy
      • 20.2.6.5.2. Product Strategy
      • 20.2.6.5.3. Channel Strategy
  • 20.2.7. F. Hoffmann-La Roche Ltd
    • 20.2.7.1. Overview
    • 20.2.7.2. Product Portfolio
    • 20.2.7.3. Key Financials
    • 20.2.7.4. Sales Footprint
    • 20.2.7.5. Strategy Overview
      • 20.2.7.5.1. Marketing Strategy
      • 20.2.7.5.2. Product Strategy
      • 20.2.7.5.3. Channel Strategy
  • 20.2.8. GenMark Diagnostics, Inc.
    • 20.2.8.1. Overview
    • 20.2.8.2. Product Portfolio
    • 20.2.8.3. Key Financials
    • 20.2.8.4. Sales Footprint
    • 20.2.8.5. Strategy Overview
      • 20.2.8.5.1. Marketing Strategy
      • 20.2.8.5.2. Product Strategy
      • 20.2.8.5.3. Channel Strategy
  • 20.2.9. Luminex Corporation
    • 20.2.9.1. Overview
    • 20.2.9.2. Product Portfolio
    • 20.2.9.3. Key Financials
    • 20.2.9.4. Sales Footprint
    • 20.2.9.5. Strategy Overview
      • 20.2.9.5.1. Marketing Strategy
      • 20.2.9.5.2. Product Strategy
      • 20.2.9.5.3. Channel Strategy
  • 20.2.10. Meridian Bioscience, Inc
    • 20.2.10.1. Overview
    • 20.2.10.2. Product Portfolio
    • 20.2.10.3. Key Financials
    • 20.2.10.4. Sales Footprint
    • 20.2.10.5. Strategy Overview
      • 20.2.10.5.1. Marketing Strategy
      • 20.2.10.5.2. Product Strategy
      • 20.2.10.5.3. Channel Strategy
  • 20.2.11. Quidel Corporation
    • 20.2.11.1. Overview
    • 20.2.11.2. Product Portfolio
    • 20.2.11.3. Key Financials
    • 20.2.11.4. Sales Footprint
    • 20.2.11.5. Strategy Overview
      • 20.2.11.5.1. Marketing Strategy
      • 20.2.11.5.2. Product Strategy
      • 20.2.11.5.3. Channel Strategy
  • 20.2.12. Thermo Fisher Scientific Inc.
    • 20.2.12.1. Overview
    • 20.2.12.2. Product Portfolio
    • 20.2.12.3. Key Financials
    • 20.2.12.4. Sales Footprint
    • 20.2.12.5. Strategy Overview
      • 20.2.12.5.1. Marketing Strategy
      • 20.2.12.5.2. Product Strategy
      • 20.2.12.5.3. Channel Strategy
  • 20.2.13. Hologic
    • 20.2.13.1. Overview
    • 20.2.13.2. Product Portfolio
    • 20.2.13.3. Key Financials
    • 20.2.13.4. Sales Footprint
    • 20.2.13.5. Strategy Overview
      • 20.2.13.5.1. Marketing Strategy
      • 20.2.13.5.2. Product Strategy
      • 20.2.13.5.3. Channel Strategy

21. Assumptions and Acronyms Used

22. Research Methodology

관련자료